You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 10,538,755


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,538,755
Title:Long-acting coagulation factors and methods of producing same
Abstract: Polypeptides comprising at least one carboxy-terminal peptide (CTP) of chorionic gonadotropin attached to the carboxy terminus but not to the amino terminus of a coagulation factor and polynucleotides encoding the same are disclosed. Pharmaceutical compositions comprising the polypeptides and polynucleotides of the invention and methods of using and producing same are also disclosed.
Inventor(s): Fima; Udi Eyal (Dvira, IL), Hart; Gili (Shoham, IL)
Assignee: OPKO Biologics Ltd. (Kiryat Gat, IL)
Application Number:15/484,776
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,538,755

Introduction

Patent analysis is a crucial step in understanding the intellectual property landscape, particularly for businesses and inventors looking to protect and commercialize their innovations. This article provides a comprehensive and critical analysis of the claims and the patent landscape surrounding United States Patent 10,538,755.

Understanding the Patent

Patent Overview

United States Patent 10,538,755, like any other patent, consists of several key components: the abstract, description, drawings, and most critically, the claims. The claims define the scope of the invention and are the legal basis for determining infringement.

Claims Analysis

The claims section is the heart of any patent, as it outlines what the inventor is seeking to protect. Here are some key points to consider when analyzing the claims of US Patent 10,538,755:

Independent and Dependent Claims

  • Independent claims stand alone and define the invention without reference to other claims. They are typically broader and more general.
  • Dependent claims, on the other hand, refer back to an independent claim and add additional limitations, making them narrower and more specific[2].

Claim Structure and Hierarchy

  • The hierarchy of claims is crucial. Independent claims are the foundation, while dependent claims build upon them. Tools like the Patent Matrix software can help in parsing and compressing these claims to facilitate a clearer understanding[2].

Claim Scope and Interpretation

  • The scope of the claims can be significantly affected by legal precedents, such as the Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd. case, which can limit the doctrine of equivalents and invoke prosecution history estoppel for amended claims[2].

Patent Landscape Analysis

Global and National Patent Databases

To analyze the patent landscape, one must search through various patent databases. The USPTO's Patent Public Search tool, for instance, allows for full-text searching of patent grants and applications from the United States and over 100 other patent offices worldwide[5].

Cooperative Patent Classification (CPC)

  • The CPC database is a valuable resource for finding relevant classification schemes. This helps in identifying similar patents and understanding the broader technological context[1].

PATENTSCOPE and Global Dossier

  • PATENTSCOPE provides access to international Patent Cooperation Treaty (PCT) applications and patent documents from national and regional patent offices. The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices[1][5].

Prior Art and Citation Analysis

Common Citation Document (CCD)

  • The CCD application consolidates prior art cited by all participating offices for the family members of a patent application, enabling a comprehensive view of the prior art landscape on a single page[5].

Public Search Facility and PTRCs

  • Resources like the USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) provide access to patent and trademark information and offer training in patent search techniques[5].

Litigation and Enforcement

Patent Litigation Docket Report Data

  • The USPTO's Patent Litigation Docket Report Data provides detailed information on patent litigation cases, including litigating parties, court locations, and case types. This data can help in understanding the enforcement landscape and potential risks[4].

Role of AI in Patent Analysis

AI Tools and Patent Drafting

  • AI tools are increasingly used in patent drafting and analysis. However, it is crucial to disclose the use of AI tools to the USPTO if they are material to patentability. This includes assessing whether AI contributions rise to the level of inventorship[3].

Automated Claim Analysis

  • Tools like the Patent Claims Analysis System can automate the import, parsing, and compression of patent claims, significantly reducing the time and effort required to review large numbers of claims[2].

Challenges and Trends in Patent Analysis

Increasing Complexity

  • The number of patent applications and claims is growing rapidly, making it more challenging to conduct thorough analyses. This trend is driven by technological innovation and facilitated by advancements in technology such as word processing and remote electronic database searching[2].

Legal and Regulatory Considerations

  • Legal precedents and regulatory guidance, such as that from the USPTO on the use of AI tools, play a significant role in shaping the patent landscape. Practitioners must stay updated on these developments to ensure compliance and effective patent strategy[3].

Case Study: US Patent 10,538,755

Claims Breakdown

  • A detailed breakdown of the claims in US Patent 10,538,755 would involve identifying the independent and dependent claims, analyzing their hierarchy, and understanding the scope and limitations of each claim.

Prior Art and Citation Analysis

  • Conducting a thorough search using tools like PATENTSCOPE and the Common Citation Document (CCD) to identify prior art and understand the citation landscape.

Litigation Risk Assessment

  • Using the Patent Litigation Docket Report Data to assess the litigation history and potential risks associated with the patent.

Key Takeaways

  • Claims Analysis: The claims section is critical and must be thoroughly analyzed to understand the scope of the invention.
  • Patent Landscape: Utilize global and national patent databases, CPC, PATENTSCOPE, and Global Dossier to understand the broader technological context.
  • AI Tools: Leverage AI for automated claim analysis but ensure compliance with USPTO guidelines.
  • Legal and Regulatory Considerations: Stay updated on legal precedents and regulatory guidance to ensure effective patent strategy.
  • Litigation and Enforcement: Assess litigation risks using detailed data from the Patent Litigation Docket Report.

FAQs

What is the importance of claims in a patent?

Claims define the scope of the invention and are the legal basis for determining infringement. They are the most critical part of a patent.

How can AI tools assist in patent analysis?

AI tools can automate the import, parsing, and compression of patent claims, reducing the time and effort required to review large numbers of claims. However, their use must be disclosed to the USPTO if material to patentability[2][3].

What resources are available for conducting a comprehensive patent search?

Resources include the USPTO's Patent Public Search tool, Cooperative Patent Classification (CPC) database, PATENTSCOPE, Global Dossier, and the Common Citation Document (CCD)[1][5].

How does the Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd. case impact patent claims?

This case interpreted that narrowing amendments to claims elements made during patent prosecution can significantly limit the scope of patent claims by eliminating the doctrine of equivalents and invoking prosecution history estoppel for the amended claims[2].

What is the significance of the Patent Litigation Docket Report Data?

This data provides detailed information on patent litigation cases, helping in understanding the enforcement landscape and potential risks associated with a patent[4].

Sources

  1. Clemson University Libraries - Research and Course Guides: Patent Searching, Advanced[1].
  2. Google Patents - US20110138338A1 - Patent Claims Analysis System and Method[2].
  3. Buchanan Ingersoll & Rooney PC - U.S. Patent Office Issues Additional Guidance on Use of AI Tools[3].
  4. United States Patent and Trademark Office - Working papers and book chapters[4].
  5. United States Patent and Trademark Office - Search for patents[5].

More… ↓

⤷  Subscribe

Details for Patent 10,538,755

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 January 15, 1974 10,538,755 2029-07-09
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 December 27, 1984 10,538,755 2029-07-09
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 15, 1985 10,538,755 2029-07-09
Ferring Pharmaceuticals Inc. NOVAREL chorionic gonadotropin For Injection 017016 February 16, 1990 10,538,755 2029-07-09
Bel-mar Laboratories, Inc. CHORIONIC GONADOTROPIN chorionic gonadotropin Injection 017054 March 26, 1974 10,538,755 2029-07-09
Ferring Pharmaceuticals Inc. A.P.L. chorionic gonadotropin For Injection 017055 December 13, 1974 10,538,755 2029-07-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.